Clinical Trials Directory

Trials / Unknown

UnknownNCT02219061

Early Waning of Maternal Measles and Meningitis C Antibodies

Observation Study on Early Waning of Maternal Measles and Meningitis C Antibodies

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Guangzhou Center for Disease Control and Prevention · Other Government
Sex
All
Age
7 Months
Healthy volunteers
Accepted

Summary

Maternal antibodies (measles and meningitis C) may wane in the first six months after birth. * Geometric mean titers(GMTs) of measles and meningitis C. * Follow-up on 0 month, 3rd month,5th month and 7th month after birth.

Detailed description

Measles and meningitis C are hot topics in China in recent years. Although China had set the goal of measles elimination, many measles cases were found to be those aged \< 8 months and meningitis C is becoming public health issue since meningitis group A has been controlled at a very low level and little is known on C group. So the investigators designed the observation study on the two antibodies. Maternal antibodies are supposed to wane after birth. Serums of the placenta(0 month), children of 3 months, 5 months and 7 months old will be collected and the geometric mean titers (GMTs) of measles and meningitis C will be confirmed by using the ELISA test.

Conditions

Timeline

Start date
2014-05-01
Primary completion
2014-10-01
Completion
2014-12-01
First posted
2014-08-18
Last updated
2014-09-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02219061. Inclusion in this directory is not an endorsement.

Early Waning of Maternal Measles and Meningitis C Antibodies (NCT02219061) · Clinical Trials Directory